Cited by 96Herpesvirus Infections and TreatmentsInfectious Encephalopathies and EncephalitisCytomegalovirus and herpesvirus research

Varicella Zoster Virus Encephalitis in Denmark From 2015 to 2019—A Nationwide Prospective Cohort Study

Open access
Herlin, Laura Krogh, Hansen, Kristoffer Skaalum, Bodilsen, Jacob, Larsen, Lykke, Brandt, Christian, Andersen, Christian Østergaard, Hansen, Birgitte Rønde, Lüttichau, Hans Rudolf +5 more·2021·Clinical Infectious Diseases

Abstract

Background: Knowledge of the epidemiology and clinical characteristics of varicella zoster virus (VZV) encephalitis remains limited. Methods: Nationwide prospective cohort study of adults treated for microbiologically confirmed VZV encephalitis at Danish departments of infectious diseases from 2015 to 2019. Modified Poisson regression analysis was used to compute adjusted relative risks (RRs) of unfavorable outcome. Results: We identified 92 adults (49% female) with VZV encephalitis, yielding an incidence of 5.3/1 000 000 per year (95% CI, 4.2–6.6). Median age was 75 years (IQR, 67–83) and immunocompromising conditions were frequent (39%). Predominant symptoms were confusion (76%), headache (56%), nausea (45%), gait disturbance (42%), and personality changes (41%). Cranial imaging showed cerebral vasculitis (including infarction and hemorrhage) in 14 (16%) patients and encephalitic abnormalities in 11 (13%) with predilection for the brainstem and deep brain structures. Intravenous acyclovir treatment was initiated a median (IQR) of 13.4 hours (5.2–46.3) since admission, while cranial imaging and lumbar puncture were performed after 6.3 hours (2.5–31.0) and 18.5 hours (4.9–42.0). In-hospital, 1-month, and 3-month mortalities were 4%, 9%, and 11%, respectively. Unfavorable outcome (Glasgow Outcome Score of 1–4) was found in 69% at discharge, with age (adjusted RR [aRR], 1.02; 95% CI, 1.01–1.03), vasculitis (aRR, 1.38; 95% CI, 1.02–1.86), and Glasgow Coma Scale (GCS) <15 (aRR, 1.32; 95% CI, 1.01–1.73) identified as independent risk factors. Conclusions: VZV encephalitis occurs primarily in elderly or immunocompromised patients with a higher incidence than previously estimated. The diagnosis is often delayed; risk factors for unfavorable outcome are age, cerebral vasculitis, and GCS <15.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciaa185

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies assessing prognosis using hard endpoints in the post-acyclovir era showed neurological impairment in 20-60% of VZV patients upon hospital discharge, 55% after one month, 51% after three months, and 71% after one year after the acute episode.

    “Studies assessing prognosis using hard endpoints in the post-acyclovir era showed neurological impairment in 20–60% of patients upon hospital discharge [62–64], 55% after one month, 51% after three months and 71% after one year [62, 65] after the acute episode.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Britton PN, Eastwood K, Paterson B, et al. Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand. Intern Med J 2015; 45:563-576.

Cited by

Sorted by citations

Authors
Herlin, L. K., Hansen, K. S., Bodilsen, J., Larsen, L., Brandt, C., Andersen, C. Ø., Hansen, B. R., Lüttichau, H. R., Helweg-Larsen, J., Wiese, L., Storgaard, M., Nielsen, H., & Mogensen, T. H.
Affiliations
  • Aarhus University Hospital (DK)
  • Aalborg University Hospital (DK)
  • University of Southern Denmark (DK)
  • Nordsjællands Hospital (DK)
  • Hvidovre Hospital (DK)
  • Herlev Hospital (DK)
  • Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark
  • Roskilde Sygehus (DK)
  • Aarhus University (DK)
Corresponding author
Herlin, Laura Krogh
Venue
Clinical Infectious Diseases
Published
2020-02-27
Volume
72
Issue
7
Pages
1192-1199
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W3008855890
Cited by
96
References
31
Citations by year
2026: 13 · 2025: 14 · 2024: 25 · 2023: 17 · 2022: 14 · 2021: 9 · 2020: 4
FWCI
7.88
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, other-oa)
  • VBN Forskningsportal (Aalborg Universitet) (submittedVersion, other-oa)
Funders
  • Lundbeckfonden (R268‐406 2016‐3927, 4004-00047B)
  • H. Lundbeck A/S
Topics
  • Health Sciences › Medicine › Epidemiology › Herpesvirus Infections and Treatments
  • Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
  • Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Keywords
varicella-zoster virus encephalitis, varicella-zoster virus reactivation, incidence, immunocompromised adults, cerebral vasculitis, brainstem involvement, Glasgow Outcome Scale, mortality, risk factors, elderly patients, Denmark
MeSH terms
Acyclovir, Adult, Aged, Denmark, Female, Herpes Zoster, Humans, Male, Prospective Studies, Herpesvirus 3, Human, Encephalitis, Varicella Zoster

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review